Age and sex distribution of the study population (%)
| High-risk patients | Low-risk patients | All patients | |||
| Kidney disease | Diabetes mellitus | Cardiovascular* | |||
| Age, years | |||||
| Mean | 67.0 | 56.8 | 57.1 | 55.6 | 57.3 |
| Median | 69.0 | 57.0 | 57.0 | 56.0 | 57.0 |
| Male, % | 42.0 | 58.2 | 50.9 | 50.5 | 50.9 |
| Obese/overweight, % | 61.4 | 83.8 | 66.4 | 65.7 | 67.5 |
| Current tobacco use, % | 20.3 | 25.8 | 25.1 | 23.7 | 24.5 |
| Number of patients | 3060 | 4303 | 29 175 | 11 593 | 48 131 |
| % of patients | 6.4 | 8.9 | 60.6 | 24.1 | 100.0 |
*The cardiovascular risk group includes patients with grades 2 or 3 hypertension (with or without comorbid cardiovascular disease) prior to treatment initiation and those with ‘high normal’ or grade 1 hypertension plus one or more cardiovascular conditions (ie, coronary heart disease, cerebrovascular disease, peripheral vascular disease, myocardial infarction or hyperlipidaemia).